Clinical Trial Update: ACE-D Aim 3 Clinical Cognitive Trial to Enhance Translation in Depression [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update from Stanford on ACE-D Aim 3 to enhance translation in depression. Recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Snippet

Sponsor: Stanford University | Conditions: Depression | Phase 2 | Status: RECRUITING